Cargando…

Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse: Results from the PENELOPE-B trial

BACKGROUND: Patients with hormone receptor-positive, HER2-negative breast cancer who have residual invasive disease after neoadjuvant chemotherapy (NACT) are at a high risk of relapse. PENELOPE-B was a double-blind, placebo-controlled, phase III trial that investigated adding palbociclib (PAL) for t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galactionova, Katya, Loibl, Sibylle, Salari, Paola, Marmé, Frederik, Martin, Miguel, Untch, Michael, Bonnefoi, Hervé R., Kim, Sung-Bae, Bear, Harry D., McCarthy, Nicole, Gelmon, Karen A., García-Sáenz, José A., Kelly, Catherine M., Reimer, Toralf, Toi, Masakazu, Rugo, Hope S., Gnant, Michael, Makris, Andreas, Burchardi, Nicole, Schwenkglenks, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484462/ https://www.ncbi.nlm.nih.gov/pubmed/36132153 http://dx.doi.org/10.3389/fonc.2022.886831

Ejemplares similares

Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib
por: Zhu, Zhou, et al.
Publicado: (2022)

La Penélope normanda
por: Karr, Alphonse, 1808-1890

Correction to: Cost-Effectiveness, Burden of Disease and Budget Impact of Inclisiran: Dynamic Cohort Modelling of a Real-World Population with Cardiovascular Disease
por: Galactionova, Katya, et al.
Publicado: (2022)

Cost-Effectiveness, Burden of Disease and Budget Impact of Inclisiran: Dynamic Cohort Modelling of a Real-World Population with Cardiovascular Disease
por: Galactionova, Katya, et al.
Publicado: (2022)

Penélope en la guerra /
por: Fallaci, Oriana
Publicado: (1980)

El oficio de Penélope /
por: Garza Rapport, Sonya
Publicado: (1987)

Subcutaneous injection of trastuzumab into the thigh versus abdominal wall in patients with HER2-positive early breast cancer: Pharmacokinetic, safety and patients' preference - Substudy of the randomised phase III GAIN-2 study
por: Reinisch, Mattea, et al.
Publicado: (2022)

Penélope y las doce criadas /
por: Atwood, Margaret, 1939-
Publicado: (2005)

Avoiding Axillary Sentinel Lymph Node Biopsy after Neoadjuvant Systemic Therapy in Breast Cancer: Rationale for the Prospective, Multicentric EUBREAST-01 Trial
por: Reimer, Toralf, et al.
Publicado: (2020)

Palbociclib with Letrozole in Postmenopausal Women with ER+/HER2− Advanced Breast Cancer: Hematologic Safety Analysis of the Randomized PALOMA‐2 Trial
por: Diéras, Véronique, et al.
Publicado: (2019)

Molecular dissection of Penelope transposable element regulatory machinery
por: Schostak, Nataliya, et al.
Publicado: (2008)

The complete mitochondrial genome of Anas penelope (Anatidae: Anas)
por: Sun, Xiaoping, et al.
Publicado: (2020)

Sísifo y penélope : invenciones y asombros varios sobre la ciencia en México y en el mundo entero
por: Pérez-Tamayo, Ruy
Publicado: (1984)

Long-term Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for HR+/HER2- Advanced Breast Cancer
por: Diéras, Véronique, et al.
Publicado: (2018)

Eukaryotic Penelope-Like Retroelements Encode Hammerhead Ribozyme Motifs
por: Cervera, Amelia, et al.
Publicado: (2014)

Self-triggering readout system for the neutron lifetime experiment PENeLOPE
por: Gaisbauer, D, et al.
Publicado: (2016)

Self-triggering readout system for the neutron lifetime experiment PENeLOPE
por: Gaisbauer, D, et al.
Publicado: (2016)

PENELOPE/PRIMO-calculated photon and electron spectra from clinical accelerators
por: Brualla, Lorenzo, et al.
Publicado: (2019)

Real-world comparative effectiveness of palbociclib plus letrozole versus letrozole in older patients with metastatic breast cancer
por: Rugo, Hope S., et al.
Publicado: (2023)

Real-World Effectiveness of Palbociclib Plus Aromatase Inhibitors in African American Patients With Metastatic Breast Cancer
por: Rugo, Hope S, et al.
Publicado: (2023)

Palbociclib Combined with an Aromatase Inhibitor in Patients with Breast Cancer with Lung or Liver Metastases in US Clinical Practice
por: Brufsky, Adam, et al.
Publicado: (2023)

Overall Survival with Palbociclib and Fulvestrant in Women with HR(+)/HER2(−) ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study
por: Cristofanilli, Massimo, et al.
Publicado: (2022)

An Ancient Transkingdom Horizontal Transfer of Penelope-Like Retroelements from Arthropods to Conifers
por: Lin, Xuan, et al.
Publicado: (2016)

Complete mitogenome and phylogenetic analysis of two species (Mareca penelope and Mareca falcate)
por: Lee, Seon-Mi, et al.
Publicado: (2021)

Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor‐positive/human epidermal growth factor receptor 2‐negative metastatic breast cancer
por: Gelmon, Karen A., et al.
Publicado: (2019)

Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 and PALOMA-3 clinical trials
por: Finn, Richard S., et al.
Publicado: (2020)

Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial
por: Rugo, H S, et al.
Publicado: (2018)

Real-world treatment patterns and effectiveness of palbociclib plus an aromatase inhibitor in patients with metastatic breast cancer aged 75 years or older
por: Brufsky, Adam, et al.
Publicado: (2023)

Long‐Term Pooled Safety Analysis of Palbociclib in Combination with Endocrine Therapy for Hormone Receptor‐Positive/Human Epidermal Growth Factor Receptor 2‐Negative Advanced Breast Cancer: Updated Analysis with up to 5 Years of Follow‐Up
por: Finn, Richard S., et al.
Publicado: (2021)

Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast Cancer
por: O’Leary, Ben, et al.
Publicado: (2020)

Palbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast cancer
por: Durairaj, Chandrasekar, et al.
Publicado: (2018)

FLUKA and PENELOPE simulations of 10keV to 10MeV photons in LYSO and soft tissue
por: Chin, M P W, et al.
Publicado: (2014)

Neutropenia management with palbociclib in Japanese patients with advanced breast cancer
por: Masuda, Norikazu, et al.
Publicado: (2019)

Real-world study of overall survival with palbociclib plus aromatase inhibitor in HR+/HER2− metastatic breast cancer
por: Rugo, Hope S., et al.
Publicado: (2022)

Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor–Positive Metastatic Breast Cancer
por: Turner, Nicholas C., et al.
Publicado: (2019)

Draft Genome Sequence of Multidrug-Resistant Stenotrophomonas pavanii BWK1, Isolated from Mareca penelope Feces
por: Kenzaka, Takehiko, et al.
Publicado: (2018)

Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up
por: Rugo, H. S., et al.
Publicado: (2019)

Drivers of differences in expected public health impact of RTS,S in individual countries of Africa: an individual-based modeling study
por: Penny, Melissa, et al.
Publicado: (2014)

Clinical Relevance of Collagen Protein Degradation Markers C3M and C4M in the Serum of Breast Cancer Patients Treated with Neoadjuvant Therapy in the GeparQuinto Trial
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2019)

What happens when Penelope comes?: An unusual retroelement invades a host species genome exploring different strategies
por: Evgen’ev, Michael B.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_al5h3dufir6da0rbeku0qv3m81